Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2012
06/14/2012US20120149652 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
06/14/2012US20120149651 Caveolin peptides and their use as therapeutics
06/14/2012US20120149650 Diphtheria Toxin Variant
06/14/2012US20120149649 Short-chain cationic polyamino acid and use thereof
06/14/2012US20120149645 Compositions and modulation of myocyte enhancer factor 2 (mef2)
06/14/2012US20120149640 Peptides modulating the activity of igf-1 and the applications of said peptides
06/14/2012US20120149636 Modified Leptin Polypeptides and Their Uses
06/14/2012US20120149635 Treatment for obesity
06/14/2012US20120149597 Protein fragment complementation assays for high-throughput and high-content screening
06/14/2012US20120149591 In vitro peptide expression library
06/14/2012US20120149590 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
06/14/2012US20120149130 Polypeptides for the in vitro assessment of the sensitising potential of a test compound
06/14/2012US20120149102 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
06/14/2012US20120149095 Dna promoters and anthrax vaccines
06/14/2012US20120149089 Animal product free system and process for purifying a botulinum toxin
06/14/2012US20120149084 Fusion proteins
06/14/2012US20120149062 High Purity Lipopeptides
06/14/2012US20120149044 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
06/14/2012US20120149034 Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders
06/14/2012US20120148642 Multi-domain amphipathic helical peptides and methods of their use
06/14/2012US20120148625 Anti-bacterial Vaccine Compositions
06/14/2012US20120148624 Mutants of cholesterol-dependent cytolysins and uses thereof
06/14/2012US20120148618 Multiple variants of meningococcal protein nmb1870
06/14/2012US20120148616 Neisseria meningitidis antigens and compositions
06/14/2012US20120148615 Polypeptides from non-typeable haemophilus influenzae
06/14/2012US20120148614 Interaction of Moraxella Catarrhalis with Epithelial Cells, Extracellular Matrix Proteins and the Complement System
06/14/2012US20120148605 Immunomodulatory Methods And Systems For Treatment And/Or Prevention Of Atherosclerosis And Related Proteins, Peptide And Compositions
06/14/2012US20120148602 Cancer Treatment With Endothelin Receptor Antagonists
06/14/2012US20120148601 Bacterial superantigen vaccines
06/14/2012US20120148596 Molecular conjugates comprising human monoclonal antibodies to dendritic cells
06/14/2012US20120148591 Antibodies That Bind Amyloid Oligomers
06/14/2012US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
06/14/2012US20120148589 Human cancer-related gene, its encoded products and applications
06/14/2012US20120148573 Compositions and methods for the diagnosis and treatment of immune disorders
06/14/2012US20120148552 Method and compositions for enhanced anti-tumor effector functioning of t cells
06/14/2012US20120148540 Proliferated cell lines and uses thereof
06/14/2012US20120148498 Compositions and Methods for the Systemic Treatment of Arthritis
06/14/2012US20120147987 Method and apparatus for data transmission using multiple transmit antennas
06/14/2012CA2820908A1 Truncated her2 srm/mrm assay
06/14/2012CA2820837A1 Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof
06/14/2012CA2820681A1 Use of chimeric antigen receptor-modified t cells to treat cancer
06/14/2012CA2820630A1 Dimeric molecular complexes with free cysteine residues and conjugates thereof
06/14/2012CA2819978A1 Immune restricted peptides with increased efficacy
06/14/2012CA2819810A1 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
06/14/2012CA2819038A1 Humanized antibodies to liv-1 and use of same to treat cancer
06/13/2012EP2463373A2 Gene coding for an auxin receptor protein derived from the rice plant, and applications therefor
06/13/2012EP2463362A1 Simian subfamily c adenovirus SAdv-31 and uses thereof
06/13/2012EP2463307A1 Modified chaperonin 10
06/13/2012EP2463301A1 Synthetic, defined fibronectin mimetic peptides and surfaces modified with the same
06/13/2012EP2463300A2 GalNAc specific binding molecules and uses thereof
06/13/2012EP2463299A2 Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
06/13/2012EP2463298A1 Reproductive ablation constructs
06/13/2012EP2463297A1 Compositions and methods for the delivery of oxygen
06/13/2012EP2463296A1 Compositions and methods for the delivery of oxygen
06/13/2012EP2463295A1 Compositions and methods for the delivery of oxygen
06/13/2012EP2463294A1 Compositions and methods for the delivery of nitric oxide
06/13/2012EP2463269A1 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/13/2012EP2462950A1 Strongly inactivated and still highly immunogenic vaccine, and process of manufacturing thereof
06/13/2012EP2462948A1 Bacterial virulence factors and uses thereof
06/13/2012EP2462947A1 PRAME derived peptides and immunogenic compositions comprising these
06/13/2012EP2462946A1 Method of inhibiting cathepsin activity
06/13/2012EP2462945A2 Method of inhibiting angiogenesis, tumorigenesis and cathepsin activity
06/13/2012EP2462930A1 Induction of an immune response against dengue virus using prime-boost approach
06/13/2012EP2462160A1 Porphyromonas gingivalis polypeptides
06/13/2012EP2462159A1 Immunogenic composition comprising variants of staphylococcal clumping factor a
06/13/2012EP2462156A1 Method of producing a sweet protein
06/13/2012EP2462155A1 Novel antipathogenic peptides
06/13/2012EP2461827A2 Virus-like particle vector as a polyvalent platform for intracellular delivery of high-molecular-weight therapeutic substances, method for generating a virus like particle vector and use of a virus-like particle vector and a pharmaceutical composition containing said virus-like particle vector
06/13/2012EP2461825A2 Anti-rsv immunogens and methods of immunization
06/13/2012EP2461819A2 Methods and compositions for treating trinucleotide repeat disorders
06/13/2012EP2461800A2 Controlled release formulations of lipocalin muteins
06/13/2012EP2461681A1 Use of melanocortins to treat dyslipidemia
06/13/2012EP2461667A2 Transgenic plants having increased biomass
06/13/2012EP2352750B1 Buffers for controlling the ph of bone morphogenetic proteins
06/13/2012EP2124548B1 Disintegrin variants and pharmaceutical uses thereof
06/13/2012EP1947110B1 Intranasal vaccine for use against disease caused by enterotoxigenic escherichia coli
06/13/2012EP1874811B1 Methods for modulating bone formation and mineralization by modulating KRC activity
06/13/2012EP1812058B1 Chlamydia trachomatis antigens for vaccine and diagnostic use
06/13/2012EP1768995B1 Preparation of protective antigen from bacillus anthracis
06/13/2012EP1699460B1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/13/2012EP1678202B1 Hcv ns3-ns4a protease resistance mutants
06/13/2012EP1613273B1 Recombinant il-9 antibodies and uses thereof
06/13/2012EP1587837B1 Epitope sequences for prostate cancer diagnosis and treatment
06/13/2012EP1516058B1 Recombinant measles viruses expressing epitopes of antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions
06/13/2012EP1494697B1 Monomeric and dimeric fluorescent protein variants and methods for making same
06/13/2012EP1490110B1 Anti-alpha v beta 6 antibodies
06/13/2012EP1480666B1 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
06/13/2012EP1449542B1 Hgf as genetic remedy for parkinson's disease
06/13/2012EP1447095B1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
06/13/2012EP1442057B1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1409646B1 Transgenic animals comprising a humanized immune system
06/13/2012EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa
06/13/2012EP0451216B2 Humanized immunoglobulins and their production and use
06/13/2012CN1930301B Methods for identifying proteins with starch phosphorylating enzymatic activity
06/13/2012CN1759122B Methods and compositions involving MDA-7
06/13/2012CN1606567B Antimicrobial polypeptides from pseudoplectania nigrella
06/13/2012CN1483831B Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 2916